ArticleObstetrics and gynecology international2026
HIV Testing in Patients Diagnosed With CIN2 or Worse: Experience at The Jessop Wing Colonoscopy Unit, Sheffield, UK.
Article in Obstetrics and gynecology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- HIV Testing in Patients Diagnosed With CIN2 or Worse: Experience at The Jessop Wing Colonoscopy Unit, Sheffield, UK.Obstetrics and gynecology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Debate regarding the value of HIV screening in English colposcopy services is ongoing. With no national guidance provided by the NHSCSP, few colposcopy services offer HIV testing. Sheffield colposcopy introduced standardised HIV testing in January 2023. We assessed prevalence rates and acceptability to HIV testing in our referred population with moderate or worse dyskaryosis, CIN2 or worse. Methods: A retrospective service evaluation with interval analysis was conducted on 1st January to 31st December 2023 at the Jessop Wing Colposcopy Service, Sheffield, UK. All patients with moderate dyskaryosis or worse on referral cytology, CIN2 or worse on biopsy, were offered an HIV test. Results: Of 367 eligible patients, six (1.6%) were known HIV positive. HIV prevalence rates in patients referred with moderate or worse cytology (16.34 per 1000) (95% confidence interval 6-35), and CIN2 or worse (12.46 per 1000) (95% confidence interval 3-28) were high in comparison with overall prevalence rates for Sheffield (2.14 per 1000). HIV testing was offered to 296 (82%) patients and accepted by 246 (83%). All HIV test results were reported as not detected. Sixty-five (18%) were not offered a test. Consultant colposcopists ( Conclusion: Acceptance of HIV testing in patients attending colposcopy is high, but willingness to offer the test varies at both local and national levels. Whilst there were no new HIV diagnoses in our sampled cohort, knowledge of HIV status is a key prognostic indicator and crucial for determining ongoing management. National societies must join forces and provide national guidance for the colposcopy community regarding HIV testing in colposcopy services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.